DarioHealth Corp.: 10-K filed 2014-03-04

Name: DarioHealth Corp.: 10-K filed 2014-03-04
Creator: DarioHealth Corp.

What DarioHealth Corp. reported in its annual report filed 2014-03-04 (fiscal FY 2013): 23 published measures, 61 facts as tagged in accession 0001144204-14-013289.

This filing

Form: 10-K (annual report)
Filed: 2014-03-04
Fiscal period: fiscal FY 2013
Accession: 0001144204-14-013289 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	4,115,814	USD
At 2012-12-31	2,315,453	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-12-31	-86,381	USD
At 2012-12-31	-1,069,043	USD
At 2011-12-31	193,144	USD
At 2011-08-10	0	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-12-31	2,263,395	USD
At 2012-12-31	1,230,034	USD
At 2011-12-31	908,765	USD
At 2011-08-10	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-13,931,778	USD	365
2011-08-11 to 2013-12-31	-20,003,700	USD	874
2012-01-01 to 2012-12-31	-5,686,573	USD	366
2011-08-11 to 2011-12-31	-385,349	USD	143

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,400,373	USD	365
2011-08-11 to 2013-12-31	2,042,558	USD	874
2012-01-01 to 2012-12-31	534,634	USD	366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-12-31	1,144,800	USD
At 2012-12-31	617,364	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	2,388,415	USD	365
2011-08-11 to 2013-12-31	2,778,818	USD	874
2012-01-01 to 2012-12-31	390,403	USD	366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-13,562,398	USD	365
2011-08-11 to 2013-12-31	-17,771,519	USD	874
2012-01-01 to 2012-12-31	-3,974,408	USD	366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	2,929,847	USD
At 2012-12-31	1,666,544	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	1,506,144	USD
At 2012-12-31	566,755	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	4,912,457	USD	365
2011-08-11 to 2013-12-31	6,491,617	USD	874
2012-01-01 to 2012-12-31	1,501,265	USD	366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	20,071,816	shares
At 2012-12-31	14,547,689	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-12-31	19,915,313	USD
At 2012-12-31	5,001,425	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-12-31	1,969,701	USD
At 2012-12-31	642,185	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-12-31	824,901	USD
At 2012-12-31	24,821	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-12-31	591,071	USD
At 2012-12-31	232,327	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-12-31	474,818	USD
At 2012-12-31	401,522	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-12-31	0	USD
At 2012-12-31	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-13,931,778	USD	365
2011-08-11 to 2013-12-31	-20,003,700	USD	874
2012-01-01 to 2012-12-31	-5,686,573	USD	366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	6,295,538	USD	365
2011-08-11 to 2013-12-31	8,629,512	USD	874
2012-01-01 to 2012-12-31	2,177,156	USD	366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	839,249	USD	365
2011-08-11 to 2013-12-31	864,070	USD	874
2012-01-01 to 2012-12-31	24,317	USD	366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-75,838	USD	365
2011-08-11 to 2013-12-31	-348,128	USD	874
2012-01-01 to 2012-12-31	-105,787	USD	366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-369,380	USD	365
2011-08-11 to 2013-12-31	-2,232,181	USD	874
2012-01-01 to 2012-12-31	-1,712,165	USD	366

Inspect the source

Entity: DarioHealth Corp. / CIK 0001533998
Captured: 2026-09-20T09:16:34.053Z
SEC response SHA-256: 8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))